MiR-27b-3p has been shown to act as a tumor suppressor of DLBCL, and its overexpression reduced the phosphorylation of AKT and extracellular signal-regulated kinases through inhibition of MET [29]. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.